📊 Evidence-Based Reference

Philips Ict CT System

Philips Medical Systems (Cleveland)

Compare similar devices

Summary: The Philips iCT CT System is a computed tomography device used for diagnostic imaging. It is primarily used in scenarios requiring detailed anatomical visualization, such as embolization procedures. Key evidence highlights its efficacy in image quality and dose reduction.

FDA Clearance Information

Pathway ? 510(k)
Number ? K162838 ↗
Decision Date ? April 7, 2017
Product Code ? JAK
Device Class ? Class 2
Evidence ? 419 studies

The Philips iCT CT System received FDA clearance through the 510(k) pathway on April 7, 2017. It is manufactured by Philips Medical Systems and is classified as a Class 2 device.

What It Is

The Philips iCT CT System is a computed tomography scanner designed for high-resolution imaging. It utilizes advanced reconstruction algorithms to enhance image quality while minimizing radiation exposure, making it suitable for a wide range of diagnostic applications.

FDA-Cleared Indications

  • Computed tomography imaging of the body for diagnostic purposes.
  • Acquisition of cross-sectional images to support evaluation of anatomical structures.
  • Use in clinical imaging workflows where CT image quality and radiation-dose management are required.

Clinical Applications

  • Diagnostic CT imaging of anatomical structures.
  • CT evaluation of the chest, abdomen, pelvis, head, and extremities when clinically indicated.
  • Imaging before, during, or after selected image-guided procedures, including embolization planning or assessment.
  • Vascular and nonvascular anatomical assessment using CT protocols appropriate to the clinical question.

Reported off-label uses

  • CT-based procedural navigation or three-dimensional planning beyond the specific indications described in the device labeling.
  • Research and investigational imaging protocols that are not part of the cleared clinical workflow.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 12 studies, comprising various study types such as RCTs and prospective analyses, conducted between 2019 and 2024. These studies focus on image quality, dose optimization, and clinical efficacy.

Reported Outcomes

Published studies report that the Philips iCT CT System provides high-quality diagnostic images with reduced radiation doses. Studies highlight its effectiveness in liver and pulmonary imaging, demonstrating non-inferiority to standard-dose CT protocols.

Safety Profile

Reported complications include minimal adverse events related to radiation exposure, as the device employs dose-reduction technologies. No significant safety concerns were identified in the reviewed studies.

Evidence Limitations

The evidence is limited by the relatively small sample sizes and the focus on specific clinical scenarios. Further research is needed to explore long-term outcomes and broader clinical applications.

Practical Considerations

  • This is a CT system, not an MRI scanner; it uses ionizing radiation and is not considered MRI-safe equipment.
  • Radiation dose depends on the body region, scan protocol, patient size, contrast use, and reconstruction settings. Protocols should be optimized for the clinical question.
  • Intravenous iodinated contrast may be used for selected examinations and requires assessment of allergy history, kidney function, and other clinical risks.
  • Patient weight, positioning, bore dimensions, table limits, and available accessories should be checked before scanning.
  • The system requires trained operators, routine quality assurance, preventive maintenance, and compatibility with the facility's imaging and data systems.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips iCT CT System?

The Philips iCT CT System is indicated for diagnostic imaging in scenarios requiring detailed anatomical visualization, such as embolization procedures and vascular assessments.

What outcomes have been reported in clinical studies?

Clinical studies have reported high-quality diagnostic images with reduced radiation doses, demonstrating effectiveness in liver and pulmonary imaging.

What complications have been reported?

Reported complications include minimal adverse events related to radiation exposure, with no significant safety concerns identified in the reviewed studies.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you